Future Drug Sales Predictions Highlight Importance of Follow-on Biologics Legislation

According to Patent Docs, "six of the top ten selling drugs by 2014 will be biologics. Today, half of the top ten best-selling drugs are conventional small molecule drugs, as shown in the table below; in terms of sales, these drugs account for about 61% of the revenues garnered by the top ten best-selling drugs."

Check out the chart : Top 10 Drug Products by Sales in 2008

But by 2014, the number of drugs sold that are biologics "are predicted to account for a 75% of the revenues, an almost 2-fold increase in the relative contributions of biologic drugs to the sector."

Check out the chart: Top 10 Drug Products by Sales in 2014

According to the article, "some traditional Big Pharma companies stand to benefit from their association (partnering) or acquisition of biotechnology companies, with Roche being a clear example as purveyors of three of the top ten predicted best-selling drugs in 2014."

For more information, please click here.

Future Drug Sales Predictions Highlight Importance of Follow-on Biologics Legislation

Gather with other professionals to discuss the emerging trends in Pharma, including biopharma strategy, R&D, product marketing, clinical studies-- join Future of BioPharma, today!

Share this article with your social network, just click below to share now!

Share |